1 Pharmacists will play a critical role in educating patients on dose titration schedules, administration requirements, and management of gastrointestinal adverse effects to optimize adherence and outcomes
Risk is still graver for an additional cohort with CAD determined to be refractory to all available treatments, with numbers estimated to reach 1.8 million in prevalence and an additional 50,000 in annual incidence in the United States
The lack of monitoring means we cannot determine from existing clinical trial data whether semaglutide causes clinically significant b12 deficiency in typical patients
Together, well develop a personalized treatment plan to help you lose weight and feel your best inside and out with the appropriate medications and lifestyle changes
oral capsules are simpler to use, easier to store, and more convenient for travel The clinical decision between oral and injectable BPC-157 is primarily one of therapeutic goal rather than patient preference, though preference is a real factor